4
Changes in Ownership
Inhibitor Therapeutics, Inc. Filed Acc 0000899243-17-007154
Director gave up 356,400 shares (to pay taxes)
- Director acquired 900,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watson W. Mark Director | 2017-03-08 | Option exercise | +300,000 | 310,000 | D | ||
| Watson W. Mark Director | 2017-03-08 | Shares withheld for taxes | −118,800 | $0.34 | $40,392 | 191,200 | D |
| Watson W. Mark Director | 2017-03-08 | Option exercise | +400,000 | 591,200 | D | ||
| Watson W. Mark Director | 2017-03-08 | Shares withheld for taxes | −158,400 | $0.34 | $53,856 | 432,800 | D |
| Watson W. Mark Director | 2017-03-08 | Option exercise | +200,000 | 632,800 | D | ||
| Watson W. Mark Director | 2017-03-08 | Shares withheld for taxes | −79,200 | $0.34 | $26,928 | 553,600 | D |
| Derivatives | |||||||
| Watson W. Mark Director | 2017-03-08 | Option exercise · Restricted Stock Units | −300,000 | 0 | D | ||
| Watson W. Mark Director | 2017-03-08 | Option exercise · Restricted Stock Units | −400,000 | 0 | D | ||
| Watson W. Mark Director | 2017-03-08 | Option exercise · Restricted Stock Units | −200,000 | 0 | D | ||
Loading xslF345X03/doc4.xml…